{"id":6758,"date":"2021-04-19T09:49:18","date_gmt":"2021-04-19T09:49:18","guid":{"rendered":"https:\/\/lupus.treefrog.dev\/en-juillet-2021-gsk-a-recu-lautorisation-de-sotrovimab-en-vertu-de-larrete-durgence-de-sante-canada\/"},"modified":"2024-05-15T04:45:36","modified_gmt":"2024-05-15T04:45:36","slug":"en-juillet-2021-gsk-a-recu-lautorisation-de-sotrovimab-en-vertu-de-larrete-durgence-de-sante-canada","status":"publish","type":"post","link":"https:\/\/www.lupuscanada.org\/fr\/en-juillet-2021-gsk-a-recu-lautorisation-de-sotrovimab-en-vertu-de-larrete-durgence-de-sante-canada\/","title":{"rendered":"En juillet 2021, GSK a re\u00e7u l\u2019autorisation de Sotrovimab en vertu de l\u2019arr\u00eat\u00e9 d\u2019urgence de Sant\u00e9 Canada"},"content":{"rendered":"\n<p>En juillet 2021, GSK a re\u00e7u l\u2019autorisation en vertu de l\u2019arr\u00eat\u00e9 d\u2019urgence de Sant\u00e9 Canada concernant le sotrovimab pour injection afin de traiter la COVID-19 chez les adultes et les adolescents \u00e0 risque \u00e9lev\u00e9. Pour en savoir plus, rendez-vous <a href=\"https:\/\/ca.gsk.com\/en-ca\/media\/press-releases\/gsk-receives-authorization-under-health-canada-s-interim-order-for-sotrovimab-for-injection-to-treat-covid-19-in-high-risk-adults-and-adolescents\/\" target=\"_blank\" rel=\"noopener\">sur https:\/\/ca.gsk.com\/en-ca\/media\/press-releases\/gsk-receives-authorization-under-health-canada-s-interim-order-for-sotrovimab-for-injection-to-treat-covid-19-in-high-risk-adults-and-adolescents\/<\/a><\/p>\n\n<p>GSK a \u00e9galement annonc\u00e9 le 6 janvier que le gouvernement du Canada avait achet\u00e9 des doses suppl\u00e9mentaires : <a href=\"https:\/\/ca.gsk.com\/en-ca\/media\/press-releases\/gsk-announces-additional-purchase-agreements-with-the-government-of-canada-for-covid-19-monoclonal-antibody-therapy-sotrovimab\/\" target=\"_blank\" rel=\"noopener\">https:\/\/ca.gsk.com\/en-ca\/media\/press-releases\/gsk-announces-additional-purchase-agreements-with-the-government-of-canada-for-covid-19-monoclonal-antibody-therapy-sotrovimab\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En juillet 2021, GSK a re\u00e7u l\u2019autorisation en vertu de l\u2019arr\u00eat\u00e9 d\u2019urgence de Sant\u00e9 Canada concernant le sotrovimab pour injection afin de traiter la COVID-19 chez les adultes et les adolescents \u00e0 risque \u00e9lev\u00e9. Pour en savoir plus, rendez-vous sur https:\/\/ca.gsk.com\/en-ca\/media\/press-releases\/gsk-receives-authorization-under-health-canada-s-interim-order-for-sotrovimab-for-injection-to-treat-covid-19-in-high-risk-adults-and-adolescents\/ GSK a \u00e9galement annonc\u00e9 le 6 janvier que le gouvernement du Canada avait achet\u00e9 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[92],"tags":[],"topic":[113],"audience":[121,123,122,126,125,124],"class_list":["post-6758","post","type-post","status-publish","format-standard","hentry","category-article-fr","topic-nouvelles-et-evenements","audience-ai-je-le-lupus","audience-j-ai-le-lupus","audience-j-ai-recemment-recu-un-diagnostic","audience-je-veux-plaider","audience-professionnel-de-la-sante","audience-une-personne-a-qui-je-tiens-a-le-lupus"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/posts\/6758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/comments?post=6758"}],"version-history":[{"count":0,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/posts\/6758\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/media?parent=6758"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/categories?post=6758"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/tags?post=6758"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/topic?post=6758"},{"taxonomy":"audience","embeddable":true,"href":"https:\/\/www.lupuscanada.org\/fr\/wp-json\/wp\/v2\/audience?post=6758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}